Innoviz Technologies Ltd (INVZ) concluded trading on Thursday at a closing price of $0.94, with 4.96 million shares of worth about $4.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 75.87% during that period and on May 29, 2025 the price saw a loss of about -1.09%. Currently the company’s common shares owned by public are about 198.96M shares, out of which, 198.96M shares are available for trading.
Stock saw a price change of 4.06% in past 5 days and over the past one month there was a price change of 26.73%. Year-to-date (YTD), INVZ shares are showing a performance of -44.26% which decreased to -15.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.45 but also hit the highest price of $3.14 during that period. The average intraday trading volume for Innoviz Technologies Ltd shares is 3.17 million. The stock is currently trading 7.61% above its 20-day simple moving average (SMA20), while that difference is up 26.34% for SMA50 and it goes to 5.62% higher than SMA200.
Innoviz Technologies Ltd (NASDAQ: INVZ) currently have 198.96M outstanding shares and institutions hold larger chunk of about 27.50% of that.
The stock has a current market capitalization of $186.33M and its 3Y-monthly beta is at 0.96. It has posted earnings per share of -$0.45 in the same period. It has Quick Ratio of 4.23 while making debt-to-equity ratio of 0.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVZ, volatility over the week remained 5.47% while standing at 5.88% over the month.
Analysts are in expectations that Innoviz Technologies Ltd (INVZ) stock would likely to be making an EPS of -0.09 in the current quarter, while forecast for next quarter EPS is -0.09 and it is -0.27 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.1 which is -0.08 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.13 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 45.61% while it is estimated to increase by 13.71% in next year. EPS is likely to grow at an annualized rate of 27.75% for next 5-years, compared to annual growth of -463.21% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Rosenblatt on December 20, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. On July 11, 2024, Goldman Downgrade their recommendations, while on October 25, 2022, Rosenblatt Initiated their ratings for the stock with a price target of $5. Stock get a Buy rating from Berenberg on September 28, 2022.
